Deals in Depth: March 2011
Executive Summary
Takeda's deals with Intra-Cellular Therapies ($500 million) and Dainippon Sumitomo Pharma ($302 million) for their neurology assets topped the alliance list. Blood processing firm CaridianBCT was scooped up by Terumo for $2.6 billion in the biggest M&A of the month. Biopharma companies raised significantly less capital in March - $676 million - pulling in less than half of February's $1.9 billion. Total device fundraising drppoed from $367 million to $184 million.